Rx Product News (August 2016)

Contemporary ClinicAugust 2016
Volume 2
Issue 4

Read about the new Rx Products featured in August.


Marketed by:Biofrontera

Indication:Ameluz (BF-200 ALA) is a photo- dynamic therapy treatment for mild to moderate actinic keratosis on the face and scalp. The product should be used in conjunction with the BF-RhodoLED medical device and administered under the supervision of a health profes- sional familiar with photodynamic therapy. Ameluz is set to launch by September 2016.

Dosage Form:Topical gel: 78 mg/g For More



Marketed by:Promius Pharma, LLC

Indication:Sernivo (beta- methasone dipropionate) is FDA-approved for the treatment of mild to moderate plaque psoriasis in patients 18 years or older. The commercial launch of the product is planned for the coming quarter. Dosage Form: Spray: 0.05%

For More Information:drreddys.com


Marketed by: Camber Pharmaceuticals Compare to: Zyvox (Pfizer) Indication: Camber Pharmaceuticals has launched Linezolid Tablets, the generic equivalent to Zyvox, in a 600-mg tablet strength. The drug is indicated to treat several types of bacterial infections, including pneumonia, skin infections, and other antibiotic-resistant infections.

Dosage Form:Tablets: 600 mg

For More Information: camberpharma.com

© 2023 MJH Life Sciences

All rights reserved.